Covered recipient · General Payments record
BHARAT JENIGIRI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$8,035.53
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $843.91 | 44 |
| Education | $137.01 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $175.09 | 5 |
| Karyopharm Therapeutics Inc. | $123.29 | 1 |
| PFIZER INC. | $99.73 | 10 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.56 | 4 |
| Acerta Pharma LLC | $55.16 | 2 |
| Daiichi Sankyo Inc. | $35.51 | 2 |
| AVEO Pharmaceuticals, Inc. | $34.32 | 2 |
| ABBVIE INC. | $33.94 | 2 |
| GlaxoSmithKline, LLC. | $24.68 | 1 |
| Blueprint Medicines Corporation | $23.16 | 1 |
| TerSera Therapeutics LLC | $22.96 | 1 |
| Astellas Pharma US Inc | $21.72 | 1 |
| Gilead Sciences, Inc. | $21.12 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.55 | 1 |
| Ipsen Biopharmaceuticals, Inc | $19.03 | 1 |
| Genentech USA, Inc. | $17.43 | 1 |
| Merck Sharp & Dohme Corporation | $17.10 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.94 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.10 | 1 |
| Tempus AI, Inc | $15.85 | 1 |
| Celgene Corporation | $15.59 | 1 |
| TOLMAR, INC. | $14.61 | 1 |
| Lilly USA, LLC | $14.28 | 1 |
| Coherus Biosciences Inc. | $14.21 | 1 |
| Alexion Pharmaceuticals, Inc. | $14.03 | 1 |
| Novocure Inc. | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (47)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.